Raptor Pharma (RPTP) Gains on New PROCYSBI Patents and Orphan Drug Exclusivity Extension
Tweet Send to a Friend
Raptor Pharma (NASDAQ: RPTP) is gaining sharply after the company announced this morning that a U.S. PROCYSBI patent, number 9,233,077 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
